97296 ⎘
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Methods and compositions for inhibiting CD32B expressing cells
#4202C-Met antibody combinations
#4203Anti-IL13 antibodies and uses thereof
#4204ANTI-JAM-A ANTIBODIES
#4205COMPOSITIONS AND METHODS FOR DETECTING OR ELIMINATING SENESCENT CELLS TO DIAGNOSE OR TREAT DISEASE
#4206USE OF HER3 BINDING AGENTS IN PROSTATE TREATMENT
#4207YKL-40 monoclonal antibody
#4208Apoptotic anti-IgE antibodies
#4209BISPECIFIC ANTI-EGFR/ANTI-IGF-1R ANTIBODIES
#4210INHIBITION OF MIGRATION INHIBITORY FACTOR IN THE TREATMENT OF DISEASES INVOLVING CYTOKINE-MEDIATED TOXICITY
#4211Anti c-Met antibodies
#4212Anti-CD79B antibodies and immunoconjugates and methods of use
#4213Methods for treating a tumor using an antibody that specifically binds GRP94
#4214HUMAN CANCER-RELATED GENE, ITS ENCODED PRODUCTS AND APPLICATIONS
#4215VEGF-SPECIFIC ANTAGONISTS FOR ADJUVANT AND NEOADJUVANT THERAPY AND THE THREATMENT OF EARLY STAGE TUMORS
#4216Antibodies to OX-2/CD200 and uses thereof
#4217Methods and compositions for inhibiting CD32b expressing cells
#4218TRANSGENIC ANIMALS EXPRESSING HUMAN IGE-M1'
#4219Antibodies against human angiopoietin 2
#4220Pharmaceutical Composition Containing Antagonist of EGF Family Ligand as Component
#4221Antibodies against human angiopoietin 2
#4222Specific binding agents of human angiopoietin-2
#4223Monoclonal antibodies capable of simultaneously binding domains II and IIIc of type 1 fibroblast growth factor receptor
#4224COMPOSITIONS AND METHODS FOR DELIVERING ANTI-ACTIVATED RAS ANTIBODIES
#4225Antibodies that specifically bind to Aβ oligomers and uses thereof
#4226Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
#4227DETECTING CANCER WITH ANTI-CXCL13 AND ANTI-CXCR5 ANTIBODIES
#4228High affinity human antibodies to human IL-4 receptor
#4229COMPOSITIONS AND METHODS FOR USING MULTISPECIFIC-BINDING PROTEINS COMPRISING AN ANTIBODY-RECEPTOR COMBINATION
#4230POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS & ANTAGONISTS
#4231Therapeutic agents for alzheimer's disease and cancer
#4232Anti-CXCL13 and anti-CXCR5 antibodies for the prevention and treatment of cancer and cancer cell migration
#4233Diagnosis and treatment of cancer using anti-TMPRSS11E antibody
#4234Anti-FGF19 antibodies and methods using same
#4235mTOR INHIBITOR AND ANGIOGENESIS INHIBITOR COMBINATION THERAPY
#4236ANTI-ESTROGEN AND IMMUNE MODULATOR COMBINATIONS FOR TREATING BREAST CANCER
#4237Methods and compositions for bi-specific targeting of CD19/CD22
#4238Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof
#4239BISPECIFIC ANTI-HER ANTIBODIES
#4240THERAPEUTIC COMPOSITIONS AND METHODS
#4241Humanized AXL antibodies
#4242COMPOSITIONS AND METHODS FOR DEMONSTRATING SECRETORY IMMUNE SYSTEM REGULATION OF STEROID HORMONE RESPONSIVE CANCER CELL GROWTH
#4243TARGETED BINDING AGENTS DIRECTED TO a5BETA1 AND USES THEREOF
#4244Human antibodies to human TNF-like ligand 1A (TL1A)
#4245TARGETED BINDING AGENTS DIRECTED TO UPAR AND USES THEREOF
#4246Modified Host Cells and Uses Thereof
#4247Antibody having anti-cancer activity
#4248Immunogenic compositions of antigens
#4249Antibodies And Epitopes Specific To Misfolded Prion Protein
#4250Pharmaceutical compositions comprising antibodies binding to the intracellular domain of EBV (Epstein-Barr virus) latent membrane protein-1 (LMP1)
#4251Antibodies for epidermal growth factor receptor 3 (HER3)
#4252Pan-HER antibody composition
#4253Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44
#4254Method for treating breast cancer using antibody binding to MMP-14
#4255Ang-2 Binding Complexes and Uses Thereof
#4256Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy
#4257Anti-TAT226 antibodies and immunoconjugates
#4258Anti CEACAM1 antibodies and methods of using same
#4259Therapeutic Agent
#4260Anti-KTPAF50 antibodies and their uses in therapeutic and diagnostic methods
#4261Method for treatment of blood tumor using anti-TIM-3 antibody
#4262Anti-CD74 immunoconjugates and methods of use
#4263ANTI-IL-6 ANTIBODIES,COMPOSITIONS, METHODS AND USES
#4264Fully human antibodies specific to CADM1
#4265Method for producing antibody using “naked” expression vector expressing type II transmembrane fusion protein
#4266Anti Notch-1 antibodies
#4267ANTI-VEGF-D ANTIBODIES
#4268Dock-and-Lock (DNL) Complexes for Disease Therapy
#4269Agonistic anti-CD40 IGG2 antibodies having amino acid mutations introduced therein
#4270Method for the treatment of inflammatory disorders
#4271Methods and compositions for inhibiting the growth of hematopoietic malignant cells
#4272ANTI-ICAM-1 ANTIBODY, USES AND METHODS
#4273Dock-and-lock (DNL) constructs for human immunodeficiency virus (HIV) therapy
#4274Superagonistic anti-CD28 antibodies
#4275IL-13 binding protein
#4276HUMAN EPO MIMETIC HINGE CORE MIMETIBODIES, COMPOSITIONS, METHODS AND USES FOR PREVENTING OR TREATING GLUCOSE INTOLERANCE RELATED CONDITIONS OR RENAL DISEASE ASSOCIATED ANEMIA
#4277Methods of treating inflammation using soluble IL-17RA/RC fusion proteins
#4278ANTI-CMET ANTAGONISTS
#4279ANTI-CMET ANTAGONISTS
#4280Antibody drug conjugates (ADC) that bind to 191P4D12 proteins
#4281Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
#4282Combination of HGF Inhibitor and EGF Inhibitor to Treat Cancer
#4283METHODS FOR TREATING CANCERS AND DISEASES ASSOCIATED WITH 4-1BB (CD137) EXPRESSION
#4284Therapeutic use of anti-CS1 antibodies
#4285SUPERANTIBODY SYNTHESIS AND USE IN DETECTION, PREVENTION AND TREATMENT OF DISEASE
#4286BTLA Antibodies and Uses Thereof
#4287ANTI-CXCL16 AND ANTI-CXCR6 ANTIBODIES FOR THE PREVENTION AND TREATMENT OF CANCER AND CANCER CELL MIGRATION
#4288Therapeutic use of anti-CS1 antibodies
#4289Anti-KIR3D antibodies
#4290Tumor biomarker
#4291MODULATION OF NKG2D
#4292Therapeutic use of anti-CS1 antibodies
#4293Therapeutic use of anti-CS1 antibodies
#4294Therapeutic use of anti-CS1 antibodies
#4295Monoclonal Antibodies to Hepatocyte Growth Factor
#4296Methods For Treating Diseases and HCV Using Antibodies To Aminophospholipids
#4297Anti-VEGF antibody compositions and methods
#4298PSCA: prostate stem cell antigen and uses thereof
#4299Non-functional P2Xreceptor
#4300Combinatorial antibody libraries and uses thereof
#4301Antibody against periostin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periostin is involved
#4302Anti-VEGFR-3 antibody compositions
#4303Antibodies directed to HER-3 and uses thereof
#4304ERBB2 antibodies comprising modular recognition domains
#4305Anti-VEGF-C antibodies and methods using same
#4306THERAPEUTIC APPLICATIONS OF NONCOVALENT DIMERIZING ANTIBODIES
#4307COMPOSITIONS AND METHODS OF USE FOR BINDING MOLECULES TO DICKKOPF-1 OR DICKKOPF-4 OR BOTH
#4308AUTOPHILIC ANTIBODIES AND METHOD OF MAKING THE SAME
#4309Methods of treatment using human antibody molecules for IL-13
#4310Anti-IL-6 antibodies, compositions, methods and uses
#4311Methods of killing myeloma stem and precursor cells by administering anti-CD48 antibodies
#4312Glioblastoma multiforme-reactive antibodies and methods of use thereof
#4313Anti system ASC amino acid transporter 2 (ASCT2) antibody
#4314Antibodies for depletion of ICOS-positive cells in vivo
#4315HUMAN MONOCLONAL ANTIBODY AGAINST A COSTIMULATORY SIGNAL TRANSDUCTION MOLECULE AILIM AND PHARMACEUTICAL USE THEREOF
#4316Cells and methods for producing blocking antibodies to human RANKL
#4317Methods of treating secondary bone tumors with antibodies against PDGFR alpha
#4318Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
#4319Monoclonal antibodies directed against LG4-5 domain of alpha3 chain of human laminin-5
#4320Suppressing Bone Loss with Anti-IL-19 Antibody
#4321Human Anti-IL-6 Antibodies With Extended In Vivo Half-Life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases
#4322EFGR antibodies comprising modular recognition domains
#4323PRODUCTION OF HER RECEPTOR ANTIBODIES IN PLANT
#4324BREAST CANCER ERADICATION PROGRAM
#4325Dual variable domain immunoglobulins and uses thereof
#4326Humanized GM-CSF antibodies
#4327INHIBITION OF MIGRATION INHIBITORY FACTOR IN THE TREATMENT OF DISEASES INVOLVING CYTOKINE-MEDIATED TOXICITY
#4328Receptor gene screening for detecting or diagnosing cancer
#4329Induction of p53 expression by neutralization of neuropilin-2 for the treatment of cancers
#4330Anti-RON antibodies
#4331Antibodies against PDGFRα to inhibit tumor growth
#4332METHODS AND COMPOSITIONS FOR TREATING ALLERGIC DISEASES
#4333Antibodies specifically binding to human TSLPR and methods of use
#4334EMP2 ANTIBODIES AND THEIR THERAPEUTIC USES
#4335Anti-IL6/IL-6R antibodies
#4336VEGF antibodies comprising modular recognition domains
#4337Multispecific antibody targeting and multivalency through modular recognition domains
#4338Molecules that bind CD180, compositions and methods of use
#4339Methods and compositions for liver cancer therapy
#4340COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
#4341Degraded TPO agonist antibody
#4342COMPOSITIONS AND METHODS OF TREATING TUMORS
#4343Stable and soluble antibodies inhibiting VEGF
#4344DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
#4345Anti-BV8 antibodies and uses thereof
#4346Photosensitizing antibody-fluorophore conjugates
#4347LeY SPECIFIC BIOTHERAPEUTIC
#4348Targeting of podoplanin with lectin for use in the prevention and treatment of cancer
#4349Alpha5-beta1 antibodies and their uses
#4350Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment
#4351Antibody neutralizers of human granulocyte macrophage colony stimulating factor
#4352Antibodies to endoplasmin and their use
#4353Method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same
#4354METHODS OF TREATING BONE-LOSS DISORDERS USING A GM-CSF ANTAGONIST
#4355Folate receptor 1 antibodies and immunoconjugates and uses thereof
#4356FUNCTIONALIZED PYRROLIDINES AND USE THEREOF AS IAP INHIBITORS
#4357Humanized anti-IL-6 antibodies
#4358Antibodies to insulin-like growth factor I receptor
#4359Biologic compounds directed against death receptor 5
#4360Anti-DLL4 antibodies and uses thereof
#4361SPECIFIC BINDING PROTEINS AND USES THEREOF
#4362NOTCH1 receptor antibodies and methods of treatment
#4363Angiopoietin-2 specific binding agents
#4364Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cells
#4365WISP polypeptides and nucleic acids encoding same
#4366Method of treating immunological disorders by administering truncated BAFF receptors
#4367Inhibitors of angiopoietin-like 4 protein, combinations, and their use
#4368Antibodies and methods for treating estrogen receptor-associated diseases
#4369Isolated antibodies which bind to CXC chemokine receptor 4
#4370ISOLATED VEGF-C AND VEGF-D PEPTIDES AND USES THEREOF
#4371Treating Oral Cancer with Anti-IL-20 Antibody
#4372Treating breast cancer and inhibiting cancer-associated bone loss with anti-IL-20 antibody
#4373Anti-FGFR2 antibodies
#4374Camptothecin conjugates of anti-CD22 antibodies for treatment of B cell diseases
#4375Stabilized polypeptide compositions
#4376ANTI-CMET ANTAGONISTS
#4377Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in vivo
#4378AGENT FOR PROPHYLAXIS OR TREATMENT OF CANCER
#4379Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases
#4380Polynucleotides encoding BSL2vcvc-lg
#4381NOVEL ANTI CXCR4 ANTIBODIES AND THEIR USE FOR THE TREATMENT OF CANCER
#4382Antibodies binding to adrenomedullin receptors and uses thereof as drugs
#4383Methods of Treating and/or Preventing Cell Proliferation Disorders with IL-17 Antagonists
#4384Anti-human CLCP1 antibody and use thereof
#4385Antigen-presenting complex-binding compositions and uses thereof
#4386ISOFORM SPECIFIC ANTI-HER4 ANTIBODIES
#4387Bispecific antibodies
#4388ANNEXIN A2 AS IMMUNOLOGICAL TARGET
#4389Anticancer Composition Comprising Antitumor Agent and Substance Having Inhibitory Effects on L1CAM Activity and Expression
#4390Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#4391Compositions and Methods for Inhibiting Growth of SMAD-4 Deficient Cancers
#4392SPECIFIC BINDING PROTEINS AND USES THEREOF
#4393NOVEL ANTI CXCR4 ANTIBODIES AND THEIR USE FOR THE TREATMENT OF CANCER
#4394Methods of treatment using human anti-IL-23 antibodies
#4395VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS
#4396Neoplasm specific antibodies and uses thereof
#4397Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
#4398DDR1-binding agents and methods of use thereof
#4399Production of heteromultimeric proteins
#4400TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASE
#4401TOXIN CONJUGATED EPH RECEPTOR ANTIBODIES
#4402Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same
#4403Anti-CD98 antibody
#4404Substance specific to human PD-1
#4405HEPATOCYTE GROWTH FACTOR RECEPTOR ANTAGONISTS AND USES THEREOF
#4406Antibodies to human IL-22
#4407Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#4408Method for treating coronary artery disease using antibody binding human protein tyrosine phosphatase beta(HPTPbeta)
#4409Compositions and methods for the diagnosis and treatment of tumor
#4410Antibodies that bind colony stimulating factor 1 receptor (CSF1R)
#4411ANTIBODIES MODIFIED WITH HYDROPHOBIC MOLECULE
#4412Antibodies against vascular endothelial growth factor receptor-1
#4413Anti-NGF antibodies for the treatment of various disorders
#4414CCR3 inhibition for ocular angiogenesis and macular degeneration
#4415Process for the modulation of the antagonistic activity of a monoclonal antibody
#4416CELL-PENETRATING, SEQUENCE-SPECIFIC AND NUCLEIC ACID-HYDROLYZING ANTIBODY, METHOD FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
#4417ANTI-CD20 MONOCLONAL ANTIBODIES
#4418Antibodies that bind to PSCA proteins for diagnosis of cancer
#4419Anti-HS6ST2 antibodies and uses thereof
#4420Biological materials and uses thereof
#4421NOVEL ANTI-CD38 ANTIBODIES FOR THE TREATMENT OF CANCER
#4422Human antibodies that bind mesothelin, and uses thereof
#4423USE OF IGF-II/IGF-IIE BINDING PROTEINS FOR THE TREATMENT AND PREVENTION OF SYSTEMIC SCLEROSIS ASSOCIATED PULMONARY FIBROSIS
#4424TREATMENT METHOD
#4425NOVEL ANTIBODIES
#4426Anti-ErbB3 antibodies
#4427CD37-binding molecules and immunoconjugates thereof
#4428Methods for inhibiting tumor growth or reducing metastatic burden in a subject by administering FDF03 antibodies
#4429NOVEL METHODS AND ANTIBODIES FOR TREATING CANCER
#4430POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS & ANTAGONISTS
#4431Methods for treating osteoporosis with anti-IL-20 receptor antibodies
#4432Antibodies to CD122
#4433Inhibition of PLGF to treat philadelphia chromosome positive leukemia
#4434Anti-fXI antibodies and methods of use
#4435Combination of rocaglamide and apoptosis inducing substances for the treatment of cancer
#4436Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
#4437MN Gene and Protein
#4438Antibodies against CSF-1R
#4439Anti-CD40 antibodies
#4440CHIMERIC AND HUMANISED MONOCLONAL ANTIBODIES AGAINST INTERLEUKIN-13
#4441Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells
#4442Anti-cMet antibody
#4443Human Angiostatin Interacting and Tumor Metastasis Involving Protein Variants and Uses Thereof
#4444Bispecific, bivalent anti-VEGF/anti-ANG-2 antibodies
#4445()
#4446Methods using recombinant anti-epidermal growth factor receptor antibody compositions
#4447Hepatocyte growth factor (HGF) binding proteins
#4448PD-1 antibodies
#4449Monoclonal antibodies for treatment of cancer
#4450BASIGIN BINDING PROTEINS
#4451Humanized C-kit antibody
#4452METHODS FOR PREPARATION AND USE OF MARROW INFILTRATNG LYMPHOCTYES (MILS)
#4453ANTI-IL-6 ANTIBODIES, COMPOSITIONS, METHODS AND USES
#4454Methods of use of sialoadhesin factor-2 antibodies
#4455Therapeutic DLL4 binding proteins
#4456Nerve Growth Factor Conjugates and Uses Thereof
#4457Monoclonal antibody SC104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent
#4458MHC II Associated Protein and Uses Thereof
#4459Dual variable domain immunoglobulins and uses thereof
#4460Antibody Fc mutants with ablated effector functions
#4461Antitumor antibodies, proteins, and uses thereof
#4462SAM-6 VARIANTS, TARGET AND METHODS OF USE
#4463CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
#4464Gelsolin binding agent compositions and uses of same
#4465Fuel Cell System and Method for Operation of a Fuel Cell System
#4466SPINK1 TARGETED THERAPY
#4467METHODS FOR INHIBITING BONE LOSS AND BONE METASTASIS
#4468Methods and Compositions for Treating Neuroblastoma
#4469POLYPEPTIDES AND POLYNUCLEOTIDES FOR ARTEMIN AND RELATED LIGANDS, AND METHODS OF USE THEREOF
#4470Antigen-Binding Molecule And Uses Thereof
#4471COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN
#4472Antibodies binding to an intracellular PRL-1 or PRL-3 polypeptide
#4473Kits for detecting rank
#4474Anti-CD147 antibodies, methods and uses
#4475Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
#4476Methods of using insulin-like growth factor antibodies to treat tumors
#4477Antibodies to EGFL7 and methods for their use
#4478MONOVALENT ANTIBODY FRAGMENTS USEFUL AS THERAPEUTICS
#4479Antibodies Directed Against the Myelin Basic Protein Recognising an Epitope of CD64 and Their Use as Immunosuppressants
#4480Nucleic acids encoding human anti-IL-23 antibodies
#4481Method of treating cancer using antibodies to a non-ligand binding region of NOTCH2
#4482CD9-specific human antibodies
#4483CD20 antibodies and uses thereof
#4484CD20 antibodies and uses thereof
#4485Superagonistic anti-CD28 antibodies
#4486METHODS FOR SOLUBLE ZALPHA11 CYTOKINE RECEPTORS
#4487Methods of treating autoimmune diseases with Dll4 antagonists
#4488Methods of treating diabetes with Dll4 antagonists
#4489Chimeric Anti-VEGF-D Antibodies and Humanized Anti-VEGF-D Antibodies and Methods of Using the Same
#4490TMPRSS4-specific human antibody
#4491Human GM-CSF antigen binding proteins
#4492PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease
#4493Apo-2 Ligand
#4494METHODS OF IDENTIFYING COMBINATIONS OF ANTIBODIES WITH AN IMPROVED ANTI-TUMOR ACTIVITY AND COMPOSITIONS AND METHODS USING THE ANTIBODIES
#4495Therapeutic agent or preventive agent for osteoarthritis
#4496Monoclonal antibodies that bind to HGM-CSF and medical compositions comprising same
#4497Antibody variants
#4498ANTI-PLEIOTROPHIN ANTIBODIES AND METHODS OF USE THEREOF
#4499DEVELOPMENT OF MASKED THERAPEUTIC ANTIBODIES TO LIMIT OFF-TARGET EFFECTS: APPLICATION TO ANTI-EGFR ANTIBODIES
#4500METHOD FOR SELECTIVE DEPLETION OF CD137 POSITIVE CELLS USING ANTI-CD137 ANTIBODY-TOXIN COMPLEX